Update

Opill's manufacturer, Perrigo, said it wants to make the pill "accessible and affordable" and it's still unclear if it can be covered by insurance, although advocates are pushing for the feds to make no-cost coverage without a prescription a requirement for all over-the-counter contraceptives.

Even as COVID-19 wanes, lawyers representing the health care sector predict their days in court aren't about to end soon, as lawsuits abound questioning public health policies and hospitals' authority on mask and vaccine use.

The hospital chain, which announced last week that the breach affected 11 million patients, "knew or should have known" that the private information it collects is "highly sought after by criminal parties," plaintiffs wrote in one complaint filed last week.

Behavioral health startup Octave, which aims to expand access and reduce costs, plans to fill the large unmet need for in-network behavioral health services, including adult individual, couples and family therapy with virtual and in-person services.

A second judge ruled the DOL's 5-part test to determine what defines "fiduciary" should be struck down, which was a victory for the Federation of Americans for Consumer Choice, an advocacy group for insurance distributors.

In recent months ominous ads about prescription drugs have flooded the TV airwaves - and Congress is paying attention: House and Senate members have launched nine bills that take aim at pharmacy benefit managers.

Opioid manufacturers and distributors are paying more than $54 billion in restitution to settle lawsuits about their role in the overdose epidemic, with little oversight on how the money is spent.

As some parts of the CAA come into clearer focus, other provisions will continue to be worked out in coming years.